Katie Larson Ode

1.3k total citations
27 papers, 826 citations indexed

About

Katie Larson Ode is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Katie Larson Ode has authored 27 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Katie Larson Ode's work include Cystic Fibrosis Research Advances (20 papers), Pancreatic function and diabetes (7 papers) and Neonatal Respiratory Health Research (6 papers). Katie Larson Ode is often cited by papers focused on Cystic Fibrosis Research Advances (20 papers), Pancreatic function and diabetes (7 papers) and Neonatal Respiratory Health Research (6 papers). Katie Larson Ode collaborates with scholars based in United States, Australia and Italy. Katie Larson Ode's co-authors include Antoinette Moran, Christine L. Chan, Andrea Granados, Amir Moheet, Brigitte I. Frohnert, Andrew W. Norris, John F. Engelhardt, Yaling Yi, Xingshen Sun and Brandon M. Nathan and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Katie Larson Ode

25 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katie Larson Ode United States 16 582 232 172 113 104 27 826
S. Nousia‐Arvanitakis Greece 14 151 0.3× 172 0.7× 78 0.5× 44 0.4× 39 0.4× 23 429
Stavros Doudounakis Greece 15 433 0.7× 70 0.3× 8 0.0× 59 0.5× 43 0.4× 31 621
Anders Fernström Sweden 15 114 0.2× 98 0.4× 43 0.3× 58 0.5× 18 0.2× 43 648
Cynthia L. Hill United States 11 179 0.3× 93 0.4× 78 0.5× 10 0.1× 24 0.2× 22 408
Anne Vierzig Germany 14 491 0.8× 183 0.8× 14 0.1× 19 0.2× 102 1.0× 30 848
Giorgio Mello Italy 15 67 0.1× 123 0.5× 128 0.7× 32 0.3× 297 2.9× 21 704
Y. Yamashiro Japan 10 162 0.3× 73 0.3× 16 0.1× 44 0.4× 33 0.3× 31 427
M L Corey Canada 7 296 0.5× 105 0.5× 11 0.1× 121 1.1× 41 0.4× 9 440
A Litwin Israel 14 70 0.1× 147 0.6× 71 0.4× 52 0.5× 176 1.7× 27 539
Mahmut Öncül Türkiye 16 42 0.1× 87 0.4× 71 0.4× 33 0.3× 195 1.9× 42 782

Countries citing papers authored by Katie Larson Ode

Since Specialization
Citations

This map shows the geographic impact of Katie Larson Ode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Larson Ode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Larson Ode more than expected).

Fields of papers citing papers by Katie Larson Ode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Larson Ode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Larson Ode. The network helps show where Katie Larson Ode may publish in the future.

Co-authorship network of co-authors of Katie Larson Ode

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Larson Ode. A scholar is included among the top collaborators of Katie Larson Ode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Larson Ode. Katie Larson Ode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ode, Katie Larson, Yumi Imai, & Andrew W. Norris. (2025). Approach to the Patient With Pancreatogenic Diabetes. The Journal of Clinical Endocrinology & Metabolism. 111(2). e569–e576.
2.
Ode, Katie Larson, et al.. (2023). A provider survey of cystic fibrosis related diabetes screening and management practices at North American CF centers. Frontiers in Endocrinology. 14. 1183288–1183288. 5 indexed citations
3.
Abu‐El‐Haija, Maisam, Lindsey Hornung, Douglas S. Fishman, et al.. (2023). Bone health in children with recurrent and chronic pancreatitis: A multi-center cross sectional analysis. Pancreatology. 23(7). 755–760. 1 indexed citations
4.
Teresi, M., et al.. (2023). Patient and Caregiver Perceptions of Airway Clearance Methods Used for Cystic Fibrosis. Canadian Respiratory Journal. 2023. 1–9. 1 indexed citations
5.
Putman, Melissa S., Andrew W. Norris, Rebecca L. Hull, et al.. (2023). Cystic Fibrosis–Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes. Diabetes Care. 46(6). 1112–1123. 10 indexed citations
6.
Putman, Melissa S., Andrew W. Norris, Rebecca L. Hull, et al.. (2023). Cystic Fibrosis–Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes. Diabetes. 72(6). 677–689. 10 indexed citations
7.
Chan, Christine L., Andrea Granados, Amir Moheet, et al.. (2022). Glycemia and β-cell function before and after elexacaftor/tezacaftor/ivacaftor in youth and adults with cystic fibrosis. Journal of Clinical & Translational Endocrinology. 30. 100311–100311. 14 indexed citations
8.
Ode, Katie Larson, et al.. (2021). The role of modulators in cystic fibrosis related diabetes. Journal of Clinical & Translational Endocrinology. 27. 100286–100286. 27 indexed citations
9.
Granados, Andrea, Amir Moheet, Christine L. Chan, et al.. (2021). 18: Effect of clinical initiation of elexacaftor/tezacaftor/ivacaftor on glucose homeostasis in patients with cystic fibrosis. Journal of Cystic Fibrosis. 20. S10–S10.
10.
Ode, Katie Larson, Christine L. Chan, Andrea Granados, et al.. (2019). Cystic fibrosis related diabetes: Medical management. Journal of Cystic Fibrosis. 18. S10–S18. 33 indexed citations
11.
Sun, Xingshen, Yaling Yi, Bo Liang, et al.. (2019). Incretin dysfunction and hyperglycemia in cystic fibrosis: Role of acyl-ghrelin. Journal of Cystic Fibrosis. 18(4). 557–565. 4 indexed citations
12.
Chan, Christine L., Katie Larson Ode, Andrea Granados, et al.. (2019). Continuous glucose monitoring in cystic fibrosis – A practical guide. Journal of Cystic Fibrosis. 18. S25–S31. 30 indexed citations
13.
Granados, Andrea, Christine L. Chan, Katie Larson Ode, et al.. (2019). Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis. Journal of Cystic Fibrosis. 18. S3–S9. 104 indexed citations
14.
Moheet, Amir, Christine L. Chan, Andrea Granados, et al.. (2019). Hypoglycemia in cystic fibrosis: Prevalence, impact and treatment. Journal of Cystic Fibrosis. 18. S19–S24. 17 indexed citations
15.
Yi, Yaling, Andrew W. Norris, Kai Wang, et al.. (2016). Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 194(8). 974–980. 70 indexed citations
16.
Sui, Hongshu, Yaling Yi, Jianrong Yao, et al.. (2014). Quantifying Insulin Sensitivity and Entero-Insular Responsiveness to Hyper- and Hypoglycemia in Ferrets. PLoS ONE. 9(3). e90519–e90519. 5 indexed citations
17.
Ode, Katie Larson & Antoinette Moran. (2013). New insights into cystic fibrosis-related diabetes in children. The Lancet Diabetes & Endocrinology. 1(1). 52–58. 43 indexed citations
18.
Ode, Katie Larson, Heather Gray, Sara E. Ramel, Michael Georgieff, & Ellen W. Demerath. (2012). Decelerated Early Growth in Infants of Overweight and Obese Mothers. The Journal of Pediatrics. 161(6). 1028–1034. 21 indexed citations
19.
Ode, Katie Larson, Brigitte I. Frohnert, Theresa A. Laguna, et al.. (2010). Oral glucose tolerance testing in children with cystic fibrosis. Pediatric Diabetes. 11(7). 487–492. 84 indexed citations
20.
Ode, Katie Larson, Brigitte I. Frohnert, & Brandon M. Nathan. (2009). Identification and treatment of metabolic complications in pediatric obesity. Reviews in Endocrine and Metabolic Disorders. 10(3). 167–188. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Nousia‐Arvanitakis Breakdown of academic impact, for papers by Stavros Doudounakis Breakdown of academic impact, for papers by Anders Fernström Breakdown of academic impact, for papers by Cynthia L. Hill Breakdown of academic impact, for papers by Anne Vierzig Breakdown of academic impact, for papers by Giorgio Mello Breakdown of academic impact, for papers by Y. Yamashiro Breakdown of academic impact, for papers by M L Corey Breakdown of academic impact, for papers by A Litwin Breakdown of academic impact, for papers by Mahmut Öncül
Rankless by CCL
2026